Giudice Valentina, Feng Xingmin, Kajigaya Sachiko, Young Neal S, Biancotto Angélique
Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, Maryland, 20892-1202.
Center for Human Immunology, Autoimmunity, and Inflammation, NIH, Bethesda, Maryland, 20892-1202.
Cytometry A. 2017 Jul;91(7):694-703. doi: 10.1002/cyto.a.23162. Epub 2017 Jul 10.
Fluorescent cell barcoding (FCB) is a cell-based multiplexing technique for high-throughput flow cytometry. Barcoded samples can be stained and acquired collectively, minimizing staining variability and antibody consumption, and decreasing required sample volumes. Combined with functional measurements, FCB can be used for drug screening, signaling profiling, and cytokine detection, but technical issues are present. We optimized the FCB technique for routine utilization using DyLight 350, DyLight 800, Pacific Orange, and CBD500 for barcoding six, nine, or 36 human peripheral blood specimens. Working concentrations of FCB dyes ranging from 0 to 500 μg/ml were tested, and viability dye staining was optimized to increase robustness of data. A five-color staining with surface markers for Vβ usage analysis in CD4 and CD8 T cells was achieved in combination with nine sample barcoding. We provide improvements of the FCB technique that should be useful for multiplex drug screening and for lymphocyte characterization and perturbations in the diagnosis and during the course of disease. Published 2017 by Wiley Periodicals, Inc., on behalf of International Society for Advancement of Cytometry. This article is a US government work and as such, is in the public domain in the United States of America.
荧光细胞条形码(FCB)是一种用于高通量流式细胞术的基于细胞的多重技术。带有条形码的样本可以一起进行染色和采集,将染色变异性和抗体消耗降至最低,并减少所需的样本量。与功能测量相结合,FCB可用于药物筛选、信号分析和细胞因子检测,但存在技术问题。我们使用DyLight 350、DyLight 800、太平洋橙和CBD500对FCB技术进行了优化,以便常规用于对6个、9个或36个人外周血样本进行条形码标记。测试了浓度范围为0至500μg/ml的FCB染料工作浓度,并优化了活力染料染色以提高数据的稳健性。结合9个样本条形码标记,实现了对CD4和CD8 T细胞中Vβ使用情况分析的表面标志物的五色染色。我们对FCB技术进行了改进,这对于多重药物筛选以及淋巴细胞表征以及疾病诊断和病程中的扰动应该是有用的。由Wiley Periodicals, Inc.于代表国际细胞计量学促进协会于2017年发表。本文是美国政府工作,因此在美国属于公共领域。